12/16/2025
Take Action Now — Stand Up for AMT-130
AMT-130, a promising gene therapy for Huntington’s disease, is at risk of not getting a full, fair FDA review. After decades without a treatment that slows or stops HD, families cannot afford delays.
We need your voice!
Ask your Members of Congress to urge the FDA to allow AMT-130 to move forward to a science-driven review.
For people living with HD, every day matters.
Your message right now can help keep hope moving forward.
🔗 hdsa.org/advocacyhome/TakeAction